A group of benzamide compounds are disclosed. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The pharmaceutical compositions can arrest or slow the progressive loss of function.
申请公布号
CA2187794(A1)
申请公布日期
1995.10.26
申请号
CA19952187794
申请日期
1995.04.07
申请人
CANTAUR PHARMACEUTICALS, INC.
发明人
FLITTER, WILLIAM DAVID;MAPLES, KIRK RANDALL;PAYLOR, RICHARD EMERY;WILCOX, ALLAN LEE;TAN, HELMING